Prudential plc’s Core Laboratories CLB Stock Holding History

Prudential plc’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-400,000	Closed	-$43.8M	–	727
2017 Q4	$43.8M	Hold	400,000	–	–	0.13%	168
2017 Q3	$39.5M	Hold	400,000	–	–	0.12%	175
2017 Q2	$40.5M	Hold	400,000	–	–	0.13%	179
2017 Q1	$46.2M	Hold	400,000	–	–	0.15%	159
2016 Q4	$48M	Hold	400,000	–	–	0.17%	142
2016 Q3	$44.9M	Hold	400,000	–	–	0.17%	144
2016 Q2	$49.6M	Hold	400,000	–	–	0.19%	140
2016 Q1	$45M	Hold	400,000	–	–	0.18%	144
2015 Q4	$43.5M	Hold	400,000	–	–	0.18%	136
2015 Q3	$39.9M	Buy	400,000 +100,000	+33%	+$10.9M	0.17%	136
2015 Q2	$34.2M	Buy	+300,000	New	+$36.4M	0.13%	164

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Prudential plc's CLB Position: Q1 2018 in Review

Prudential plc sold out of Core Laboratories (CLB) in Q1 2018, closing a stake of 400,000 shares — an estimated $43.8M sold.

Prudential plc first reported a position in CLB in Q2 2015 and held it in 11 quarters. The position peaked at $49.6M in Q2 2016. 355 funds tracked by Wall St. Rank hold CLB as of Q1 2018.

Prudential plc reported no remaining Core Laboratories position as of Q1 2018 after selling out during the quarter.
Prudential plc sold 400,000 Core Laboratories shares in Q1 2018, an estimated $43.8M.
Prudential plc first reported a position in Core Laboratories in Q2 2015 and held it in 11 quarters.
Prudential plc's Core Laboratories position peaked at $49.6M in Q2 2016.
355 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2018.

Based on Prudential plc's 13F filing for Q1 2018, filed 15 May 2018.